Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
Public ClinicalTrials.gov record NCT06572917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants - A Multicenter Randomized Blinded Placebo-Controlled Trial (the SPIN RCT)
Study identification
- NCT ID
- NCT06572917
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of British Columbia
- Other
- Enrollment
- 500 participants
Conditions and interventions
Interventions
- Indomethacin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Hours to 12 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2025
- Primary completion
- Dec 30, 2028
- Completion
- Mar 30, 2031
- Last update posted
- Sep 2, 2025
2025 – 2031
United States locations
- U.S. sites
- 5
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Roseville | Roseville | California | 95661 | — |
| UC Davis Health | Sacramento | California | 95817 | — |
| University of Pittsburgh School of Medicine | Pittsburgh | Pennsylvania | 15224-1334 | — |
| Texas Health Harris Methodist Hospital Fort Worth | Fort Worth | Texas | 76104 | — |
| Welcome to Baylor Scott & White Health | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06572917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06572917 live on ClinicalTrials.gov.